An antibiotic-resistant infection outbreak has been reported at a prominent hospital in Northern Ireland. The Belfast Trust has acknowledged collaborating with the Public Health Agency to handle the emergence of a Carbapenemase-Producing Organism (CPO) at the Royal Victoria Hospital.
CPOs are bacteria with high resistance that produce enzymes capable of breaking down carbapenem antibiotics. Transmission of the infection occurs through person-to-person contact via hands, medical tools, or contaminated surfaces.
The initial case of the CPO at Royal Victoria Hospital was identified on April 28, with the formal declaration of an outbreak made two days later on April 30. Patients who have undergone extensive antibiotic treatments are at a higher risk of contracting a CPO, as reported by Belfast Live.
The hospital has implemented enhanced cleaning procedures and stringent infection control protocols. The Trust, in conjunction with the Public Health Agency, is actively engaging with the families of affected patients. Those confirmed positive for CPO will receive care in isolated rooms with appropriate protective measures for staff.
A spokesperson from the Belfast Trust stated that they are managing the CPO outbreak at Royal Victoria Hospital with guidance and support from the Public Health Agency. The outbreak primarily affects a small number of patients within the Medical Specialities and Unscheduled Care Division.
Control measures, including thorough ward cleaning, are being enforced following the Outbreak Control Group’s directives. The Trust assures that they are in communication with the families of all impacted patients and that no fatalities or severe illnesses have been directly linked to this particular CPO strain.
